SUPPLEMENTAL FIGURE LEGENDS
Supplemental Figure 1 . Evaluation of CK1γ siRNA knockdowns (A) RT-PCR analysis of CK1γ1 mRNA levels after siRNA transfection. Cells were incubated with control siRNA (C) or siRNAs specific for CK1γ1 (#1, #2, and #3) for 48 hr. Total cellular RNA was isolated and semi-quantitative RT-PCR was performed to measure the mRNA level for the kinase. β-Actin was used as a control. Relative band intensities (indicated below the panels)
were measured by using the ImageQuant program.
(B) RT-PCR analysis of CK1γ2 mRNA levels in cells treated with the indicated CK1γ2 siRNAs was carried out as described in (A).
(C) RT-PCR analysis of CK1γ3 mRNA levels in cells treated with the indicated CK1γ3 siRNAs was carried out as described in (A).
(D) Anti-human CK1γ1 antibodies were produced as described in Materials and Methods. Equal amounts (2 ng) of purified recombinant CK1γ1, CK1γ2, and CK1γ3 proteins were subjected to SDS-PAGE and immunoblotted with these anti-CK1γ1 antibodies.
(E) U2OS cells were treated with control siRNA or three different CK1γ1 siRNAs (#1, #2, and #3) for 48 hr. Whole cell lysates were immunoprecipitated with the anti-CK1γ1 antibodies and finally immunoblotted with the same antibodies. 
